Presence of Epidermal Growth Factor Receptor As an Indicator of Poor Prognosis in Patients with Breast Cancer

Overview

Journal J Clin Pathol

Specialty Pathology

Date 1985 Nov 1

PMID 2999195

Citations 40

Authors

J R Sainsbury

A J Malcolm

D R Appleton

J R Farndon

A L Harris

Affiliations

Soon will be listed here.

Abstract

Epidermal growth factor receptors are present in some breast cancers in man, and there is an inverse relation to oestrogen receptor state. We assessed the presence of epidermal growth factor receptors as a single prognostic indicator in a series of breast tumours by comparing this with the Bloom and Richardson scores for these tumours. One hundred and eight ductal tumours were examined for epidermal growth factor receptors by radioligand binding. There was a significant (p less than 0.01) correlation between the presence of the growth factor receptor and poor prognosis as assessed by the Bloom and Richardson score, suggesting that epidermal growth factor receptor state could be a useful prognostic marker. Epidermal growth factor receptor state was not significantly correlated with the lymph node state but showed a tendency to be associated with large tumours.

Citing Articles

EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both and .

Xia L, Zheng Z, Liu J, Chen Y, Ding J, Xia N Clin Transl Immunology. 2020; 9(5):e01135.

PMID: 32373345 PMC: 7196685. DOI: 10.1002/cti2.1135.

A Whole-Body Physiologically Based Pharmacokinetic Model of Gefitinib in Mice and Scale-Up to Humans.

Bi Y, Deng J, Murry D, An G AAPS J. 2015; 18(1):228-38.

PMID: 26559435 PMC: 4706283. DOI: 10.1208/s12248-015-9836-3.

Canertinib induces ototoxicity in three preclinical models.

Tang J, Qian Y, Li H, Kopecky B, Ding D, Ou H Hear Res. 2015; 328:59-66.

PMID: 26163095 PMC: 4581429. DOI: 10.1016/j.heares.2015.07.002.

Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies.

Zhou Y, Goenaga A, Harms B, Zou H, Lou J, Conrad F Mol Cancer Ther. 2012; 11(7):1467-76.

PMID: 22564724 PMC: 4209485. DOI: 10.1158/1535-7163.MCT-11-1038.

IGFBP-3 can either inhibit or enhance EGF-mediated growth of breast epithelial cells dependent upon the presence of fibronectin.

McIntosh J, Dennison G, Holly J, Jarrett C, Frankow A, Foulstone E J Biol Chem. 2010; 285(50):38788-800.

PMID: 20851879 PMC: 2998100. DOI: 10.1074/jbc.M110.177311.

References

Tonelli Q, SOROF S . Epidermal growth factor requirement for development of cultured mammary gland. Nature. 1980; 285(5762):250-2. DOI: 10.1038/285250a0. View

BLOOM H, Richardson W . Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957; 11(3):359-77. PMC: 2073885. DOI: 10.1038/bjc.1957.43. View

Adamson E, Deller M, WARSHAW J . Functional EGF receptors are present on mouse embryo tissues. Nature. 1981; 291(5817):656-9. DOI: 10.1038/291656a0. View

Stewart J, King R, Sexton S, Millis R, Rubens R, HAYWARD J . Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Eur J Cancer (1965). 1981; 17(4):449-53. DOI: 10.1016/0014-2964(81)90254-1. View

Haybittle J, Blamey R, Elston C, Johnson J, DOYLE P, Campbell F . A prognostic index in primary breast cancer. Br J Cancer. 1982; 45(3):361-6. PMC: 2010939. DOI: 10.1038/bjc.1982.62. View

Osborene C, Hamilton B, Nover M . Receptor binding and processing of epidermal growth factor by human breast cancer cells. J Clin Endocrinol Metab. 1982; 55(1):86-93. DOI: 10.1210/jcem-55-1-86. View

Imai Y, Leung C, Friesen H, Shiu R . Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture. Cancer Res. 1982; 42(11):4394-8. View

Taketani Y, Oka T . Biological action of epidermal growth factor and its functional receptors in normal mammary epithelial cells. Proc Natl Acad Sci U S A. 1983; 80(9):2647-50. PMC: 393884. DOI: 10.1073/pnas.80.9.2647. View

Libermann T, Razon N, Bartal A, Yarden Y, Schlessinger J, Soreq H . Expression of epidermal growth factor receptors in human brain tumors. Cancer Res. 1984; 44(2):753-60. View

10.

Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P . Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature. 1984; 307(5951):521-7. DOI: 10.1038/307521a0. View

11.

Howell A, Barnes D, Harland R, Redford J, Bramwell V, Wilkinson M . Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet. 1984; 1(8377):588-91. DOI: 10.1016/s0140-6736(84)90995-4. View

12.

Fitzpatrick S, Lachance M, Schultz G . Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res. 1984; 44(8):3442-7. View

13.

Fitzpatrick S, Brightwell J, Wittliff J, Barrows G, Schultz G . Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Cancer Res. 1984; 44(8):3448-53. View

14.

Perez R, Pascual M, Macias A, Lage A . Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treat. 1984; 4(3):189-93. DOI: 10.1007/BF01806484. View

15.

Nixon S, Steele R, Hawkins A, McGregor J, Forrest A . Prediction of recurrence after mastectomy for operable breast cancer. Br J Surg. 1985; 72(1):7-9. DOI: 10.1002/bjs.1800720103. View

16.

Sainsbury J, Farndon J, Sherbet G, Harris A . Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet. 1985; 1(8425):364-6. DOI: 10.1016/s0140-6736(85)91385-6. View

17.

Neal D, Marsh C, Bennett M, Abel P, Hall R, Sainsbury J . Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet. 1985; 1(8425):366-8. DOI: 10.1016/s0140-6736(85)91386-8. View

18.

Barnes D, Sato G . Methods for growth of cultured cells in serum-free medium. Anal Biochem. 1980; 102(2):255-70. DOI: 10.1016/0003-2697(80)90151-7. View